Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Medical Equipment

SANUWAVE Health Inc

+ Add to Watchlist

SNWV:US

0.0750 USD 0.0050 6.25%

As of 10:25:51 ET on 05/28/2015.

Snapshot for SANUWAVE Health Inc (SNWV)

Open: 0.0750 Day's Range: 0.0750 - 0.0750 Volume: 3,100
Previous Close: 0.0800 52wk Range: 0.0410 - 0.5450 1-Yr Rtn: -83.70%

Stock Chart for SNWV

No chart data available.
  • SNWV:US 0.0750
  • 1D
  • 1M
  • 1Y
0.0800
Interactive SNWV Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SNWV

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.0800
Est. EPS (USD) (12/2015) -
Est. PEG Ratio -
Market Cap (M USD) 4.73
Shares Outstanding (M) 63.06
30 Day Average Volume 210,386
Price/Book (mrq) -
Price/Sale (ttm) 4.4129
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/06/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SNWV

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for SNWV

SANUWAVE Health Inc. develops and commercializes noninvasive, biological response activating devices in the regenerative medicine area for the repair and regeneration of tissue, musculoskeletal and vascular structures. The Company's portfolio of products and product candidates activate biologic signaling and angiogenic responses.

Kevin A Richardson IICo-Chief Executive OfficerBarry J JenkinsCFO/COO
More Company Profile & Key Executives for SNWV

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil